Metropolitan Digital

Men's Weekly


.

IBD: How a class of killer T cells goes rogue in inflammatory bowel disease

  • Written by John Chang, Professor of Medicine, University of California San Diego
IBD: How a class of killer T cells goes rogue in inflammatory bowel diseaseThere are currently no permanent treatments for most patients with inflammatory bowel disease.PokPak05/iStock/Getty Images Plus

Between 6 and 8 million people worldwide suffer from inflammatory bowel disease, a group of chronic intestinal disorders that can cause belly pain, urgent and frequent bowel movements, bloody stools and weight loss. New...

Read more: IBD: How a class of killer T cells goes rogue in inflammatory bowel disease

More Articles ...

  1. El coronavirus puede transmitirse a través del aire. ¿Cómo se pueden detectar las partículas donde viaja el COVID-19?
  2. Los ladrillos (sí, como los de tu casa) pueden almacenar energía eléctrica
  3. Joe Biden appealed to 2 different audiences in his acceptance speech – 2 experts discuss which punches landed
  4. Why Steve Bannon faces fraud charges: 4 questions answered
  5. Mail-in voting does not cause fraud, but judges are buying the GOP's argument that it does
  6. Here's what it'll take to clean up esports' toxic culture
  7. Why companies were so quick to endorse Black Lives Matter
  8. Outdoor classes hold promise for in-person learning amid COVID-19
  9. I'm a lung doctor testing the blood from COVID-19 survivors as a treatment for the sick – a century old idea that could be a fast track to treatment
  10. Parents of bereaved children are also heroes of the pandemic – they can help build resilience in kids
Metropolitan republishes selected articles from The Conversation USA with permission

Visit The Conversation to see more